hepatitis D

Gilead

Pharma

UK's NICE signs off on Gilead's hepatitis D drug

The U.K.’s NICE has recommended Gilead's bulevirtide for the treatment of adults with HDV and compensated liver disease.

Kevin Dunleavy May 15, 2023 10:15am

After FDA rejection Gileads Hepcludex looks set for full EU nod

After FDA rejection, Gilead's Hepcludex set for full EU nod

May 5, 2023 10:36am

Gilead Sciences

FDA swats away Gilead's hepatitis D treatment bulevirtide

Oct 28, 2022 9:52am

Gilead

Late-stage data bode well for Gilead's EU-approved Hepcludex

Jun 23, 2022 11:35am